Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Non-Current Deferred Tax Liability: 2016-2020

Historic Non-Current Deferred Tax Liability for Summit Therapeutics (SMMT) over the last 4 years, with Sep 2020 value amounting to $2.1 million.

  • Summit Therapeutics' Non-Current Deferred Tax Liability was N/A to $2.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2019, which is N/A change from last year.
  • As of Q3 2020, Summit Therapeutics' Non-Current Deferred Tax Liability stood at $2.1 million, which was up 196.28% from -$2.2 million recorded in Q1 2020.
  • Over the past 5 years, Summit Therapeutics' Non-Current Deferred Tax Liability peaked at $2.1 million during Q3 2020, and registered a low of -$3.3 million during Q2 2018.
  • Over the past 3 years, Summit Therapeutics' median Non-Current Deferred Tax Liability value was -$2.2 million (recorded in 2020), while the average stood at -$1.4 million.
  • In the last 5 years, Summit Therapeutics' Non-Current Deferred Tax Liability grew by 25.65% in 2017 and then tumbled by 372.86% in 2018.
  • Quarterly analysis of 5 years shows Summit Therapeutics' Non-Current Deferred Tax Liability stood at -$855,796 in 2016, then rose by 13.16% to -$743,157 in 2017, then slumped by 198.10% to -$2.2 million in 2018, then rose by 11.67% to $2.1 million in 2019, then reached $2.1 million in 2020.
  • Its Non-Current Deferred Tax Liability stands at $2.1 million for Q3 2020, versus -$2.2 million for Q1 2020 and $2.1 million for Q4 2019.